Stevanato Group S.P.A. STVN
We take great care to ensure that the data presented and summarized in this overview for Stevanato Group S.p.A. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding STVN
View all-
Conestoga Capital Advisors, LLC8.09MShares$179 Million3.35% of portfolio
-
Neuberger Berman Group LLC New York, NY4.87MShares$108 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.55MShares$78.5 Million0.06% of portfolio
-
Times Square Capital Management, LLC3.27MShares$72.2 Million1.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.61MShares$57.7 Million0.1% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN2.37MShares$52.4 Million0.12% of portfolio
-
Bamco Inc New York, NY1.97MShares$43.6 Million0.14% of portfolio
-
Jennison Associates LLC1.56MShares$34.4 Million0.02% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.39MShares$30.7 Million0.77% of portfolio
-
Pembroke Management, LTD1.28MShares$28.3 Million3.29% of portfolio
Latest Institutional Activity in STVN
Top Purchases
Top Sells
About STVN
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Insider Transactions at STVN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|